Skip to main content
. 2021 Jul 16;142:104914. doi: 10.1016/j.jcv.2021.104914

Table 2a.

Validation study panel composition

N % Male Median age (range)
Known Positive 0-14 days post-onset 10 60 68 (44–86)
>14 days post-onset 32 53 65 (23–89)
Presumed Negative Cross-reactivity panel (Table 2b) 14 36 40 (8–77)
Other (prenatal and organ donor sera obtained prior to COVID-19) 51 2 30 (17–53)